Sarah Cannon Research Institute UK

25/04/2017

Thousands of people are being diagnosed with late-stage cancer in A&E due to GPs repeatedly misreading their symptoms, new research warns.

19/04/2017

Survival is still poor for people diagnosed with lung, pancreatic and oesophageal cancers, and brain tumours.

31/03/2017

"Immunotherapy is a term that encompasses a range of treatments designed to reprogram elements of a patient's immune response so that it can more effectively target cancer cells..."

Pioneering research is targeting cancer cells - by reprogramming our defences

30/03/2017

It can be difficult to know how to talk to your employer if you have cancer. When Cath found out she had bowel cancer, she got in touch with Macmillan for information about her rights at work.

Cath says, "I went into work to have a chat with the manager, to bring him up to speed of what was happening. And luckily Macmillan had sent me a workplace rights book, that I could take into show my manager, explaining my rights, their rights and the company's rights. My employer turned out to be totally amazing.'

Do you want to find out about your rights at work? Find out more at macmillan.org.uk/rightsatwork

28/03/2017

The tool will calculate the risk of the disease based on blood tests, symptoms and a GP's advice.

27/03/2017

Scientists from The Institute of Cancer Research, London, have been awarded £1.5 million by the charity Children with Cancer UK to advance precision medicine in the UK and improve cancer treatment…

22/03/2017

Around 41,000 people are diagnosed with bowel cancer each year, making it the fourth most common cancer in the UK.

Read the latest blog from our US Sarah Cannon Research Institute colleagues...

17/03/2017

We are lucky to have a community of supporters committed to fighting cancer by banding together! Happy to all the members!

05/03/2017

02/03/2017

What a great philosophy from one of our Sarah Cannon Research Institute HealthONE patients in Denver...

02/03/2017

A groundbreaking gene therapy treatment which boosts a patient's own immune cells has been shown to clear disease from one third of terminal patients.